Introduction
============

Xenobiotic metabolizing enzymes and transporters (XMETs) are involved in biotransformation and detoxification of carcinogens, environmental toxins, and therapeutic drugs (Carlsten et al., [@B10]; Korkina et al., [@B26]). In humans, the process of biotransformation and detoxification of xenobiotics by XMETs can be divided into three phases: modification (phase I) primarily by enzymes of the cytochromes P450 superfamily; conjugation (phase II), e.g., glucuronidation by UDP-glucuronosyl transferase; and excretion (phase III) mainly by membrane transporters. XMETs are expressed in almost all tissue types, centrally and locally protecting the entire body against the damages caused by various natural and synthetic compounds. XMETs are highly expressed in digestive tract and especially in the liver, the most important organ for central metabolism (Conde-Vancells et al., [@B13]). Variations in the expression and activity of these XMETs lead to significant inter-individual difference in the disposition of exogenous chemicals including absorption, distribution, metabolism, and excretion (ADME) of pharmaceutical drugs. On the other hand, many XMETs are also found to be very abundant in non-digestive tract tissues/cells, e.g., brain, lung, bladder, and blood (Pavek and Dvorak, [@B38]). These XMETs could affect the local response to certain drugs at the site of action. Meanwhile, due to the crucial role of XMETs in detoxification of carcinogens and toxins, genetic variation in XMETs function in specific tissues/organs is also an important mechanism underlying genetic susceptibility to certain diseases, e.g., those XMETs expressed in lung and bladder may modify cancer risk. Recent genome-wide association studies have identified polymorphisms at the *UGT1A* locus strongly associated with urinary bladder cancer risk (Selinski et al., [@B43]). XMETs are sensitively regulated by various nuclear receptors (NRs) and transcription factors (TFs). These *trans*-acting regulators play a pivotal role in mediating cellular response to exposure to xenobiotics by modulating the transcription of XMETs, thus significantly contributing to the variability in the function of XMETs (Bourgine et al., [@B7]).

Identifying the DNA polymorphisms leading to the variations in XMET function is a major area of interest in pharmacogenetic and genomic research. To date, numerous studies focused on individual XMET genes have discovered a large number of sequence variations, many of which alter protein coding sequence and consequently affecting the activity of XMETs (Adjei et al., [@B2]; Hildebrandt et al., [@B21]; Ji et al., [@B25]; Moyer et al., [@B34]; Mrozikiewicz et al., [@B35]). Meanwhile, even more variants were suggested to quantitatively modulate gene transcription (Pavek and Dvorak, [@B38]). Recently, genome-wide mapping for gene expression quantitative trait loci (eQTLs) in a few human tissues/cells offered unprecedented opportunities to identify the most influential single nucleotide polymorphisms (SNPs) determining gene expression level of XMETs (Gamazon et al., [@B17]). However, unlike the variants located in the protein coding sequences for which the causality for altered enzyme activity can be more easily understood, how eQTLs affect gene transcription is largely unknown. Understanding the underlying mechanisms will lead to identification of novel causative DNA variants for XMET function as well as reliable pharmacogenetic markers.

MicroRNAs (miRs) are single stranded, about 22-nucleotides (nt) long, evolutionarily conserved, and function as important posttranscriptional regulators of mRNA expression by binding to the 3′-UTR of target mRNAs (Ambros, [@B3]; Bartel, [@B6]). MiRs are involved in various developmental and physiological processes by negatively regulating gene expression (Zhang et al., [@B50]). Over 30% of all protein-coding genes were estimated to be regulated by miRs (Brennecke et al., [@B8]; Krek et al., [@B27]; Lewis et al., [@B28]; Lim et al., [@B30]). Due to the conservation of the miR target site, SNPs located in 3′-UTR sequences may abolish or create a miR target, thus significantly affecting the mRNA expression (Saunders et al., [@B41]). Previous studies have suggested that many XMETs are regulated by miRs (Tsuchiya et al., [@B47]; Takagi et al., [@B44]; Patron et al., [@B37]). Several studies also demonstrated that SNPs in XMET gene 3′-UTRs led to different levels of enzyme activity (Saunders et al., [@B41]; Chin et al., [@B12]). Hence, we hypothesized that it may be an important mechanism that common SNPs or their linkage disequilibrium (LD) proxies located in the XMET gene 3′-UTR sequences alter mRNA expression via interference with miR targeting. In order to identify these candidate SNPs that may significantly modulate XMET expression, in this study we used multiple published human eQTL datasets to perform an *in silico* screening for SNPs that highly correlated with mRNA level of 409 major XMET genes. The significant SNPs and/or their LD proxies located in the gene 3′-UTRs were selected to predict a potential interference with miRs. We found that 27 SNPs located in the 3′-UTR of 14 XMET genes are likely associated with gene expression via altering miR binding.

Materials and Methods
=====================

Selection of eQTLs
------------------

The general strategy for the data analysis was presented in Figure [1](#F1){ref-type="fig"}. We used the published eQTLs datasets generated from the HapMap lymphoblastoid cell lines (LCLs; Montgomery et al., [@B32]), human liver (Schadt et al., [@B42]), and human brain (Gibbs et al., [@B18]). Although additional eQTL datasets in human LCLs are also available, we chose to use the one by Montgomery et al. ([@B32]) which utilized high-throughput sequencing for the quantification of gene expression, as this technology has been suggested to produce more accurate gene expression data. To our knowledge, all datasets were collected from tissue/cells derived from individuals of Caucasian in origin. We used the online tool[^1^](#fn1){ref-type="fn"} to search statistically significant eQTLs. As our study was focused on *cis*-acting eQTLs, we used a cut-off of *p* = 10^−5^ for significance, considering the window for genomic region (500 kb) of each gene and the potential number of SNPs (1 in every 100--1,000 bp).

![**Schematic of the search for miRNAs and the associated SNPs from XMET genes**.](fgene-03-00248-g001){#F1}

Search for SNPs in LD with eQTLs
--------------------------------

To search SNPs in LD with significant eQTLs, we used the SNAP[^2^](#fn2){ref-type="fn"} program to screen the 1,000 Genome SNP data within 500 kb range of the eQTLs of interest in the CEU population with a LD level cut-off of *R*^2^ = 0.8. Annotation for the location of eQTLs and their proxies relative to the gene structure was also collected with the program. Only SNPs and/or their proxies located within the 3′-UTR of the studied genes of interest were retained for further analyses.

Prediction of SNP-miR interaction
---------------------------------

In order to predict the potential SNP-miR interaction, two programs, MicroSNiPer[^3^](#fn3){ref-type="fn"} and PolymiRTS[^4^](#fn4){ref-type="fn"} were used. The major difference between the two programs is the algorithm used to predict the target site of miRs. The PolymiRTS program used the TargetScan[^5^](#fn5){ref-type="fn"}; Lewis et al., [@B28]; Friedman et al., [@B16]) algorithm (Bao et al., [@B4]). In contrast, the MicroSNiPer program used the FASTA (Pearson and Lipman, [@B39]) alignment program to determine if a change in a nucleotide in 3′-UTR sequence would change the miR binding capability, based on the requirement of perfect Watson--Crick match to the seed 2--7 nt of miRs (Lewis et al., [@B28]). To be conservative, we used 7-mers match as the cut-off value for a positive prediction.

Results
=======

Genome-wide eQTL analysis of XMETs
----------------------------------

Expression quantitative traits loci were screened for all 409 major XMET genes, including 144 phase I, 85 phase II and 111 phase III genes, 48 NRs, and transcription factor genes as well as another 21 genes related to drug ADME (Table [A1](#TA1){ref-type="table"} in Appendix). As a result, a total of 308 significant (*p* \< 10^−5^) eQTLs were identified from 101 XMET genes. These include nine in LCL, 83 in liver, and 221 in brain tissues. Five SNPs were found as eQTLs shared in two tissue types: rs1023252 in both LCL and brain tissues, rs11101992, rs156697, rs2071474, and rs241440 in both liver and brain tissues (Figure [2](#F2){ref-type="fig"}). Among the total of 308 eQTLs, 20 SNPs were found to be located in the 3′-UTR region; 3 SNPs were in the 5′-UTRs; 171 SNPs were intronic; 8 and 6 SNPs were synonymous and non-synonymous coding variants, respectively; and 12 and 15 SNPs were located in the upstream and downstream flanking region of the genes, respectively. The remaining 73 SNPs were located in intergenic regions.

![**Significant eQTLs in different tissues**. A total of 308 significant eQTLs were identified, including 9 eQTLs in LCL, 83 in liver, and 221 in brain tissues. Five eQTLs were shared in two tissue types.](fgene-03-00248-g002){#F2}

eQTLs and their LD proxies
--------------------------

We chose to screen the 1,000 Genome SNP dataset as this would produce the most comprehensive coverage for the SNPs that may be in LD with a given eQTL. A total of 7,869 SNPs with significant LD with 260 eQTLs were identified. Combined with the remaining 48 eQTLs which had no reliable proxies in the 1,000 Genome dataset, a total of 8,177 SNPs (308 eQTLs and 7,869 proxy SNPs) were included in the subsequent analyses.

Prediction of miR-SNPs interaction
----------------------------------

Of the 112 eQTLs and proxies located in the 3′-UTR sequences, 27 SNPs were found in the 3′-UTR of 14 genes of interest. The remaining SNPs were located in nearby genes thus were excluded from the subsequent analysis. These SNPs were all common SNPs with their minor allele frequency (MAF) ≥0.067. Among the 27 SNPs, 12 were found in liver, and 15 were identified in brain tissue. More detailed information for these SNPs was listed in Table [A2](#TA2){ref-type="table"} in Appendix.

We focused our study on the association between miRs and these 27 SNPs in the 14 genes. After screened with the two algorithms, MicroSNiPer (Barenboim et al., [@B5]) and PolymiRTs (Gong et al., [@B19]), all the 27 SNPs apart from rs11807 (which is not predicted to be in a target site in PolymiRTs database) were found to potentially create, abolish, or alter the target site for miRs in both algorithms. Notably, 34 miRs were predicted by both algorithms to interact with 19 of these SNPs (Table [A2](#TA2){ref-type="table"} in Appendix). Of these 34 overlap miRs, except for rs2480256 of CYP2E1 which is not located in the seed sequence of hsa-miR-570-3p, all the remaining SNPs were found to be located in the seed sequence of miR targets.

To further validate the interaction between miRs and SNPs, we investigated whether the identified miRs were expressed in the same tissue as the identified eQTL. We used the GEO datasets (GSE21279 and GSE26545) to screen miR expression in liver and brain tissues, respectively (Hou et al., [@B22]; Hu et al., [@B23]). Since many predicted miRs were new and not probed by the published platforms, we thus only concentrate on the list of miRs probed in the platforms. Overall, over 74% (20 out of 27) of the identified miR-SNPs were found to have at least one predicted miR co-expressed with the gene of interest in the same tissue.

We further aimed to investigate whether these 27 SNPs are more likely to be targeted by miRs especially by the co-expressed miR in liver and brain tissues, compared to random-selected 3′-UTR SNPs with similar MAF. No statistical significance were found, possibly due to the limited power caused by the small number (*n* = 27) of SNPs involved (data not shown).

Discussion
==========

Although a large number of DNA variants affecting the function of XMETs have been identified, and many of them have been well linked with clinical response to pharmacotherapy or disease susceptibility (Motsinger-Reif et al., [@B33]), genetic variations in the activity of most XMETs remain incompletely explained. Recent studies continue to discover novel functional variants in XMET genes (Ramsey et al., [@B40]). Meanwhile, genome-wide association studies have found a number of XMET SNPs without previously known function significantly associated with different phenotypes in humans (Teichert et al., [@B46]; Estrada et al., [@B15]). These studies consistently suggested that additional sequence variants with fundamental role in XMET function have not been identified. Recent eQTL mapping in human tissues provided an opportunity to discover functional XMET polymorphisms at the genome-wide level. However, questions remain whether the identified eQTLs are causal for the altered gene expression and via what mechanism. Our study provides a comprehensive evaluation for this question in major human XMET genes, and generated a list of candidate SNPs that may modulate XMET genes via interference with miR targeting in multiple human tissue types.

Single nucleotide polymorphisms located in the gene 3′-UTRs could have great impact on miR targeting. It has been demonstrated that the entire 3′-UTR sequence could play important roles in miR function in addition to miR target sites (Hu and Bruno, [@B24]). In particular, negative selection in humans is stronger on computationally predicted conserved miR binding sites than on other conserved sequence motifs in 3′-UTRs, and polymorphisms in predicted miR binding sites are highly likely to be deleterious (Chen and Rajewsky, [@B11]). Gong et al. ([@B19]) mapped SNPs to the 3′-UTRs of all human protein coding genes. Their results showed that among the 225,759 SNPs identified in 3′-UTRs, over 25% of SNPs potentially abolished 90,784 original miR target sites, while another 25% created a similar number of putative miRNA target sites. Besides these *in silico* studies, a number of SNPs altering miR targeting have been experimentally demonstrated to be associated with multiple diseases as well as drug metabolism and environmental procarcinogen detoxification (Abelson et al., [@B1]; Tan et al., [@B45]; Yu et al., [@B49]; Yokoi and Nakajima, [@B48]). Although the seed sequences for miR binding are critical and highly conserved, recent studies have also suggested that 3′-UTR sequences outside of the seed sequences, e.g., flanking sequences may be equally important for miR targeting by controlling the accessibility of the miR or local RNA structure (Grimson et al., [@B20]). For example, a SNP (829C \> T) located 14 bp downstream of a miR-24 binding site in the 3′-UTR of human dihydrofolate reductase gene (*DHFR*) was demonstrated to affect *DHFR* expression by interfering with miR-24 function, resulting in *DHFR* over expression and methotrexate resistance (Mishra et al., [@B31]). By using two algorithms predicting potential SNP-miR interaction, we suggested that 27 eQTLs or their proxies in high LD for 14XMET genes may function through interference with one or more miRs, with most of the SNPs located in the seed sequences. Meanwhile, the majority (20 out of 27) of the identified miR-SNPs were found to have predicted miR co-expressed with the gene of interest in the same tissue. Although no statistically significant enrichment of miR targeting for these SNPs, the strong trends observed here warrants further experimental validations.

Our findings may also provide useful information in addition to the previous observations on the function of these SNPs. Previous studies demonstrated that SNP rs2480256 in the *CYP2E1* gene was significantly associated with systemic lupus erythematosus (Liao et al., [@B29]). Another study showed that cyclosporine A concentration in serum was significantly correlated with the genotype of the *CYP3A5* rs15524 polymorphism (Onizuka et al., [@B36]). In addition, a *GSTM3* haplotype including rs1537236 was significantly associated with a decreased growth for maximum mid-expiratory flow rate (MMEF) in a large population-based lung function study (Breton et al., [@B9]). SNP rs11807 in the 3′ region of *GSTM5* was found to be associated with hypertension (Delles et al., [@B14]). Our results thus may help further elucidate the mechanism(s) by which the SNPs are involved in the susceptibility to these specific phenotypes.

In conclusion, our study summarized the potentially interacting SNP-miRs that may affect the expression of major XMET gene, which may ultimately facilitate to elucidate the mechanism how these genes are regulated as well as how they are involved in the genetic variations in drug metabolism and disease pathogenesis. Further investigations are necessary to corroborate the hypotheses generated in this study.
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**Major XMETs and related genes investigated in this study**.

  ----------------------------------------------------------------------------------------------
  Phase I\      Phase II\    Phase III\    Nuclear receptors and\             Miscellaneous\
  (*n* = 144)   (*n* = 85)   (*n* = 111)   transcription factors (*n* = 48)   genes (*n* = 21)
  ------------- ------------ ------------- ---------------------------------- ------------------
  AADAC         AANAT        ABC1          AHR                                CRABP1

  ABP1          ACSL1        ABCA1         AHRR                               CRABP2

  ADH1A         ACSL3        ABCA2         AIP                                CYB5A

  ADH1B         ACSL4        ABCA3         ARNT                               GZMA

  ADH1C         ACSM1        ABCA7         ARNT2                              GZMB

  ADH4          ACSM2B       ABCA8         CREBBP                             MT1A

  ADH5          ACSM3        ABCB1         EP300                              MT1B

  ADH6          AGXT         ABCB10        ESR1                               MT1F

  ADH7          AS3MT        ABCB11        ESR2                               MT1H

  ADHFE1        ASMT         ABCB4         FOXA2                              MT1M

  AKR1A1        BAAT         ABCB5         FOXO1                              MT1X

  AKR1B1        CCBL1        ABCB6         HIF1A                              MT2A

  AKR1B10       CES5A        ABCB7         HIF3A                              MT3

  AKR1C1        COMT         ABCB8         HNF4A                              MT4

  AKR1C2        DDOST        ABCB9         HSP90AA1                           MTHFR

  AKR1C3        GAMT         ABCC1         KEAP1                              POR

  AKR1C4        GGT1         ABCC10        NCOA1                              RBP1

  AKR1CL1       GLYAT        ABCC11        NCOA2                              RBP2

  AKR1D1        GNMT         ABCC12        NCOA3                              TP53

  AKR1E2        GSTA1        ABCC12        NCOR1                              TXN

  AKR7A2        GSTA2        ABCC2         NCOR2                              TXN2

  AKR7A3        GSTA3        ABCC3         NFE2L2                             

  AKR7L         GSTA4        ABCC4         NR0B2                              

  ALDH16A1      GSTA5        ABCC5         NR1H2                              

  ALDH18A1      GSTK1        ABCC6         NR1H3                              

  ALDH1A1       GSTM1        ABCC8         NR1H4                              

  ALDH1A2       GSTM2        ABCC9         NR1I2                              

  ALDH1A3       GSTM3        ABCD4         NR1I3                              

  ALDH1B1       GSTM4        ABCG2         NR3C1                              

  ALDH1L1       GSTM5        ABCG8         NR3C2                              

  ALDH2         GSTO1        ALD           NR5A2                              

  ALDH3A1       GSTO2        AQP1          PPARA                              

  ALDH3A2       GSTP1        AQP7          PPARD                              

  ALDH3B1       GSTT1        AQP9          PPARG                              

  ALDH3B2       GSTT2        ATP6V0C       PPARGC1A                           

  ALDH4A1       GSTT2B       ATP7A         PPARGC1B                           

  ALDH5A1       GSTZ1        ATP7B         PPRC1                              

  ALDH6A1       HNMT         KCNK9         PTGES3                             

  ALDH7A1       INMT         MARCKSL1      RARA                               

  ALDH8A1       MGST1        MDR/TAP       RARB                               

  ALDH9A1       MGST2        MRP           RARG                               

  AOC2          MGST3        MVP           RXRA                               

  AOC3          MPST         OABP          RXRB                               

  AOX1          NAA20        OATP2         RXRG                               

  BCHE          NAT1         SLC10A1       THRA                               

  CBR1          NAT2         SLC10A2       THRB                               

  CBR3          NNMT         SLC15A1       TRIP11                             

  CBR4          PNMT         SLC15A2       VDR                                

  CEL           PTGES        SLC16A1                                          

  CES1          SAT1         SLC18A2                                          

  CES2          SULT1A1      SLC19A1                                          

  CES3          SULT1A2      SLC19A2                                          

  CES4          SULT1A3      SLC19A3                                          

  CES7          SULT1A4      SLC1A1                                           

  CYP11A1       SULT1B1      SLC1A2                                           

  CYP11B1       SULT1C2      SLC1A3                                           

  CYP11B2       SULT1C3      SLC1A6                                           

  CYP17A1       SULT1C4      SLC1A7                                           

  CYP19A1       SULT1E1      SLC21A5                                          

  CYP1A1        SULT2A1      SLC22A1                                          

  CYP1A2        SULT2B1      SLC22A11                                         

  CYP1B1        SULT4A1      SLC22A12                                         

  CYP20A1       SULT6B1      SLC22A16                                         

  CYP21A2       TPMT         SLC22A2                                          

  CYP24A1       TST          SLC22A3                                          

  CYP26A1       UGT1A1       SLC22A4                                          

  CYP26B1       UGT1A10      SLC22A5                                          

  CYP26C1       UGT1A3       SLC22A6                                          

  CYP27A1       UGT1A4       SLC22A7                                          

  CYP27B1       UGT1A5       SLC22A8                                          

  CYP27C1       UGT1A6       SLC22A9                                          

  CYP2A13       UGT1A7       SLC25A13                                         

  CYP2A6        UGT1A8       SLC28A1                                          

  CYP2A7        UGT1A9       SLC28A2                                          

  CYP2B6        UGT2A1       SLC28A3                                          

  CYP2C18       UGT2A3       SLC29A1                                          

  CYP2C19       UGT2B10      SLC29A2                                          

  CYP2C8        UGT2B11      SLC29A3                                          

  CYP2C9        UGT2B15      SLC29A4                                          

  CYP2D6        UGT2B17      SLC2A1                                           

  CYP2E1        UGT2B28      SLC31A1                                          

  CYP2F1        UGT2B4       SLC38A1                                          

  CYP2J2        UGT2B7       SLC38A2                                          

  CYP2R1        UGT3A1       SLC38A5                                          

  CYP2S1        UGT3A2       SLC3A1                                           

  CYP2U1                     SLC3A2                                           

  CYP2W1                     SLC47A1                                          

  CYP39A1                    SLC47A2                                          

  CYP3A4                     SLC5A4                                           

  CYP3A43                    SLC6A3                                           

  CYP3A5                     SLC6A4                                           

  CYP3A7                     SLC7A11                                          

  CYP46A1                    SLC7A5                                           

  CYP4A11                    SLC7A6                                           

  CYP4A22                    SLC7A7                                           

  CYP4B1                     SLC7A8                                           

  CYP4F11                    SLCO1A2                                          

  CYP4F12                    SLCO1B1                                          

  CYP4F2                     SLCO1B3                                          

  CYP4F22                    SLCO1C1                                          

  CYP4F3                     SLCO2A1                                          

  CYP4F8                     SLCO2B1                                          

  CYP4V2                     SLCO3A1                                          

  CYP4X1                     SLCO4A1                                          

  CYP4Z1                     SLCO4C1                                          

  CYP51A1                    SLCO5A1                                          

  CYP7A1                     SLCO6A1                                          

  CYP7B1                     TAP1                                             

  CYP8B1                     TAP2                                             

  DHRS2                      VDAC2                                            

  DHRS4                      VDAC3                                            

  DHRS9                                                                       

  DPYD                                                                        

  EPHX1                                                                       

  EPHX2                                                                       

  ESD                                                                         

  FMO1                                                                        

  FMO2                                                                        

  FMO3                                                                        

  FMO4                                                                        

  FMO5                                                                        

  HSD17B10                                                                    

  KCNAB1                                                                      

  KCNAB2                                                                      

  KCNAB3                                                                      

  KDM1A                                                                       

  KDM1B                                                                       

  MAOA                                                                        

  MAOB                                                                        

  NQO1                                                                        

  NQO2                                                                        

  PAOX                                                                        

  PON1                                                                        

  PON2                                                                        

  PON3                                                                        

  PTGIS                                                                       

  PTGS1                                                                       

  PTGS2                                                                       

  SPR                                                                         

  SUOX                                                                        

  TBXAS1                                                                      

  UCHL1                                                                       

  UCHL3                                                                       

  XDH                                                                         
  ----------------------------------------------------------------------------------------------

###### 

**Putative miRNAs associated with SNPs in the 3′-UTR region**.

  Gene       Classification      SNP          Tissue   Putative miRNAs                             
  ---------- ------------------- ------------ -------- --------------------- --------------------- ---------------------
  ALDH16A1   Phase I             rs1055637    Liver    hsa-miR-4265          hsa-miR-3151          hsa-miR-4669
                                                       hsa-miR-1231          hsa-miR-4447          
                                                       hsa-miR-3120-5p       hsa-miR-4472          
                                                       hsa-miR-4322          **hsa-miR-491-5p**    
                                                       hsa-miR-4669          hsa-miR-132-5p        
                                                       hsa-miR-4726-3p       hsa-miR-4669          
  CYP2E1     Phase I             rs2480256    Liver    **hsa-miR-570**       **hsa-miR-570-3p**    **hsa-miR-570-3p**
  CYP2E1     Phase I             rs2480257    Liver    hsa-miR-4762-5p       hsa-miR-5582-3p       
                                                                             **hsa-miR-570-3p**    
  CYP2U1     Phase I             rs8727       Liver    **hsa-miR-549**       **hsa-miR-549**       **hsa-miR-549**
                                                       hsa-miR-125b-2\*                            
  CYP3A5     Phase I             rs15524      Liver    hsa-miR-562           **hsa-miR-500a-5p**   **hsa-miR-500a-5p**
                                                       **hsa-miR-501-5p**    hsa-miR-5680          
                                                       hsa-miR-500b                                
                                                       **hsa-miR-500a**                            
                                                       hsa-miR-4668-3p                             
                                                       hsa-miR-3973                                
                                                       **hsa-miR-362-5p**                          
  CYP3A7     Phase I             rs10211      Liver    N/A                   **hsa-miR-125a-5p**   
                                                                             **hsa-miR-125b-5p**   
                                                                             hsa-miR-345-3p        
                                                                             hsa-miR-3920          
                                                                             hsa-miR-4319          
                                                                             hsa-miR-4732-3p       
                                                                             hsa-miR-670           
  EPHX2      Phase I             rs1042032    Brain    hsa-miR-4476          hsa-miR-183-5p        hsa-miR-2392
                                                       hsa-miR-4533          hsa-miR-2392          hsa-miR-183-5p
                                                       hsa-miR-2392                                
                                                       **hsa-miR-432\***                           
                                                       hsa-miR-761                                 
                                                       hsa-miR-183                                 
                                                       hsa-miR-3665                                
                                                       hsa-miR-32390                               
  EPHX2      Phase I             rs1042064    Brain    **hsa-miR-31**        hsa-miR-4696          hsa-miR-4696
                                                       **hsa-miR-576-3p**                          
                                                       **hsa-miR-22**                              
                                                       hsa-miR-4696                                
  GSTM3      Phase II            rs1109138    Brain    hsa-miR-4766-3p       N/A                   
                                                       hsa-miR-2964a-3p                            
                                                       **hsa-let-7i\***                            
  GSTM3      Phase II            rs1537236    Brain    hsa-miR-4762-5p       **hsa-miR-182-5p**    hsa-miR-4470
                                                       hsa-miR-4470          hsa-miR-4470          
  GSTM3      Phase II            rs1537235    Brain    hsa-miR-4790-3p       **hsa-miR-409-5p**    
  GSTM3      Phase II            rs3814309    Brain    hsa-miR-4421          hsa-miR-3130-3p       
                                                       hsa-miR-3182          hsa-miR-4793-3p       hsa-miR-4793-3p
                                                       hsa-miR-1237                                
                                                       **hsa-miR-486-5p**                          
                                                       hsa-miR-4793-3p                             
                                                       hsa-miR-3120-5p                             
                                                       hsa-miR-4527                                
                                                       **hsa-miR-29b**                             
  GSTM5      Phase II            rs11807      Liver    hsa-miR-1202          N/A                   
                                                       hsa-miR-1227                                
                                                       hsa-miR-1973                                
  MGST3      Phase II            rs8133       Liver    hsa-miR-875-3p        **hsa-miR-582-3p**    **hsa-miR-582-3p**
                                                       **hsa-miR-582-3p**    hsa-miR-875-3p        hsa-miR-875-3p
                                                       hsa-miR-4698          hsa-miR-224-3p        hsa-miR-3688-3p
                                                       hsa-miR-4694-3p       hsa-miR-3688-3p       hsa-miR-4694-3p
                                                       hsa-miR-4495          hsa-miR-4694-3p       
                                                       hsa-miR-411\*         hsa-miR-522-3p        
                                                       hsa-miR-3688-3p                             
  ATP7B      Phase III           rs928169     Liver    hsa-miR-4734          hsa-miR-4447          hsa-miR-4472
                                                       hsa-miR-4430          hsa-miR-4472          hsa-miR-4481
                                                       hsa-miR-4481          hsa-miR-4481          hsa-miR-4745-5p
                                                       hsa-miR-4472          hsa-miR-4745-5p       hsa-miR-4785
                                                       hsa-miR-3652          hsa-miR-4785          
                                                       hsa-miR-3135b         hsa-miR-4787-5p       
                                                       hsa-miR-4745-5p                             
                                                       hsa-miR-3944-3p                             
                                                       hsa-miR-1275                                
                                                       **hsa-miR-491-5p**                          
                                                       hsa-miR-4446-3p                             
                                                       hsa-miR-4498                                
                                                       hsa-miR-194\*                               
                                                       **hsa-miR-122**                             
                                                       hsa-miR-4734                                
                                                       hsa-miR-4430                                
                                                       hsa-miR-3652                                
                                                       hsa-miR-4309                                
                                                       hsa-miR-4785                                
                                                       hsa-miR-3198                                
                                                       hsa-miR-1298                                
  SLC31A1    Phase III           rs10759637   Liver    hsa-miR-4448          hsa-miR-3672          
                                                       hsa-miR-3119          hsa-miR-4524a-3p      
                                                       hsa-miR-4461                                
  TAP2       Phase III           rs13501      Brain    hsa-miR-3198          hsa-miR-1289          hsa-miR-1289
                                                       hsa-miR-1289          hsa-miR-3198          hsa-miR-3198
                                                       hsa-miR-4309          hsa-miR-4294          hsa-miR-4309
                                                       hsa-miR-3127-5p       hsa-miR-4309          
                                                                             hsa-miR-5702          
  TAP2       Phase III           rs17034      Brain    hsa-miR-4772-3p       **hsa-miR-1271-3p**   
                                                                             hsa-miR-4763-5p       
                                                                             hsa-miR-550a-3-5p     
                                                                             hsa-miR-550a-5p       
                                                                             hsa-miR-4327          
                                                                             hsa-miR-636           
  TAP2       Phase III           rs241451     Brain    hsa-miR-1260          hsa-miR-4684-5p       hsa-miR-4684-5p
                                                       hsa-miR-4758-3p                             
                                                       hsa-miR-4684-5p                             
  TAP2       Phase III           rs241452     Brain    hsa-miR-1206          hsa-miR-1206          hsa-miR-1206
                                                       **hsa-miR-1**                               
                                                       hsa-miR-4789-5p                             
  TAP2       Phase III           rs241453     Brain    hsa-miR-4298          hsa-miR-1302          hsa-miR-1302
                                                       hsa-miR-1302          hsa-miR-4298          hsa-miR-4298
  TAP2       Phase III           rs241454     Brain    hsa-miR-4476          hsa-miR-4476          hsa-miR-4476
                                                       hsa-miR-4779          hsa-miR-4533          hsa-miR-4779
                                                                             hsa-miR-3173-3p       
                                                                             hsa-miR-4779          
  TAP2       Phase III           rs241455     Brain    **hsa-miR-130a\***    hsa-miR-2116-3p       **hsa-miR-130a-5p**
                                                       **hsa-miR-323-3p**    **hsa-miR-130a-5p**   
                                                                             **hsa-miR-23a-3p**    
                                                                             **hsa-miR-23b-3p**    
                                                                             hsa-miR-23c           
                                                                             hsa-miR-3680-5p       
                                                                             hsa-miR-4798-3p       
  TAP2       Phase III           rs241456     Brain    hsa-miR-3940-5p       hsa-miR-2110          hsa-miR-4450
                                                       hsa-miR-4507          hsa-miR-3150a-3p      
                                                       **hsa-miR-92a-1\***   hsa-miR-4450          
                                                       hsa-miR-4450          **hsa-miR-450a-3p**   
                                                                             **hsa-miR-1270**      
                                                                             hsa-miR-3676-5p       
                                                                             hsa-miR-4531          
                                                                             hsa-miR-4683          
                                                                             hsa-miR-620           
  TAP2       Phase III           rs2857101    Brain    hsa-miR-944           **hsa-miR-126-5p**    hsa-miR-944
                                                       hsa-miR-4795-3p       hsa-miR-4795-3p       hsa-miR-4795-3p
                                                       hsa-miR-183\*         hsa-miR-944           
  UGT2A1     Phase II            rs4148312    Liver    hsa-miR-548t          hsa-miR-3662          hsa-miR-3662
                                                       hsa-miR-548ah         **hsa-miR-548c-3p**   hsa-miR-3609
                                                       hsa-miR-3662          hsa-miR-3609          hsa-miR-548ah-5p
                                                       hsa-miR-3646          hsa-miR-548ah-5p      hsa-miR-548t-5p
                                                       hsa-miR-3609          **hsa-miR-548n**      
                                                       **hsa-miR-340**       hsa-miR-548t-5p       
                                                       **hsa-miR-1245**                            
                                                       **hsa-miR-106a**                            
  ARNT       Nuclear receptors   rs11552229   Liver    hsa-miR-4716-5p       hsa-miR-4717-3p       

*The miRs expressed in the tissue where the eQTL was identified are highlighted in bold*.
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